Prospect Capital (PSEC) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
10 Feb, 2026Executive summary
Net investment income for the quarter was $91 million ($0.19 per share), up 5% year-over-year, with NAV at $3 billion ($6.21 per share) as of December 31, 2025.
Net assets applicable to common shares decreased to $2.96 billion, with NAV per share declining from $6.56 to $6.21 sequentially.
Distributions to common shareholders totaled $63.9 million for the quarter, with cumulative distributions since inception reaching $4.7 billion ($21.93 per share).
Strategic priorities include increasing first lien senior secured loan exposure, reducing second lien and subordinated structured notes, and exiting targeted equity-linked and real estate assets.
Portfolio rotation continues, focusing on companies with less than $50 million EBITDA and a strong emphasis on middle market lending.
Financial highlights
Total assets as of December 31, 2025, were $6.53 billion, down from $6.80 billion at June 30, 2025.
Net investment income for the quarter was $91 million; NAV stood at $3 billion ($6.21 per share).
Interest income for the 12 months ending December 2025 was 92% of total investment income, indicating a strong recurring revenue profile.
Non-accruals as a percentage of total assets were 0.7% as of December 2025.
Investment originations in the December quarter totaled $80.4 million, all in middle market investments, with $79 million in repayments and exits.
Outlook and guidance
Management expects continued volatility due to macroeconomic uncertainty, elevated interest rates, and geopolitical risks.
Monthly cash distributions of $0.045 per share have been declared for February, March, and April 2026.
Management remains focused on prudent leverage, liquidity, and balance sheet strength to capitalize on market opportunities.
Latest events from Prospect Capital
- Proposal seeks renewed authority to sell common stock below NAV, with Board support and dilution risks.PSEC
Proxy Filing11 Mar 2026 - Shareholders are asked to approve limited sales of stock below net asset value for the next year.PSEC
Proxy Filing11 Mar 2026 - Robust middle-market lender with strong returns, low risk, and disciplined financial management.PSEC
Investor presentation2 Mar 2026 - Shareholders are asked to renew approval for below-NAV stock sales, capped at 25% per sale.PSEC
Proxy Filing27 Feb 2026 - Net investment income was $102.9M, NAV $8.74, and the 86th straight dividend was declared.PSEC
Q4 202422 Jan 2026 - Net investment income fell as NAV declined and the portfolio shifted to first-lien loans.PSEC
Q1 202515 Jan 2026 - Annual meeting adjourned to January 15, 2026, to solicit more votes on key proposals.PSEC
Proxy Filing8 Jan 2026 - NII was $86.4M, NAV per share $7.84, with strong liquidity and low non-accruals at 0.4%.PSEC
Q2 202523 Dec 2025 - Annual meeting adjourned to January 8, 2026, to solicit more votes on a key proposal.PSEC
Proxy Filing16 Dec 2025